Your browser doesn't support javascript.
loading
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
Ahn, Daniel H; Uson Junior, Pedro Luiz Serrano; Masci, Peter; Kosiorek, Heidi; Halfdanarson, Thorvardur R; Mody, Kabir; Babiker, Hani; DeLeon, Thomas; Sonbol, Mohamad Bassam; Gores, Gregory; Smoot, Rory; Bekaii-Saab, Tanios; Mahipal, Amit; Mansfield, Aaron; Tran, Nguyen H; Hubbard, Joleen M; Borad, Mitesh J.
Afiliación
  • Ahn DH; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Uson Junior PLS; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Masci P; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Kosiorek H; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Halfdanarson TR; Division of Biostatistics and Informatics, Mayo Clinic, Phoenix, AZ, USA.
  • Mody K; Department of Hematology/Oncology, Mayo Clinic, Rochester, MN, USA.
  • Babiker H; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • DeLeon T; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Sonbol MB; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Gores G; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Smoot R; Division of Gastroenterology, Mayo Clinic, Rochester, MN, USA.
  • Bekaii-Saab T; Department of Hematology/Oncology, Mayo Clinic, Rochester, MN, USA.
  • Mahipal A; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Mansfield A; Department of Hematology/Oncology, Mayo Clinic, Rochester, MN, USA.
  • Tran NH; Department of Hematology/Oncology, Mayo Clinic, Rochester, MN, USA.
  • Hubbard JM; Department of Hematology/Oncology, Mayo Clinic, Rochester, MN, USA.
  • Borad MJ; Department of Hematology/Oncology, Mayo Clinic, Rochester, MN, USA.
Invest New Drugs ; 40(1): 134-141, 2022 02.
Article en En | MEDLINE | ID: mdl-34463891
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridazinas / Neoplasias de los Conductos Biliares / Colangiocarcinoma / Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos / Imidazoles Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridazinas / Neoplasias de los Conductos Biliares / Colangiocarcinoma / Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos / Imidazoles Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos